References
- Arya S, Bhargava V, Richardson J, Hawkins HK. Diffuse chorangiomatosis as a cause of cardiomegaly, microangiopathic hemolytic anemia and thrombocytopenia in a newborn. Fetal Pediatr Pathol. 2017;36(6):457–64. doi:10.1080/15513815.2017.1379041.
- Momeni Boroujeni A, Yousefi E, Vincent MT, Anderson V. Chorangiomatosis: evaluation of a placental vascular lesion and related clinical effects. Fetal Pediatr Pathol. 2014;33(5-6):331–8. doi:10.3109/15513815.2014.977620.
- Oturkar CC, Gandhi N, Rao P, Eng KH, Miller A, Singh PK, Zsiros E, Odunsi KO, Das GM. Estrogen receptor-beta2 (ERβ2)-mutant p53-FOXM1 axis: a novel driver of proliferation, chemoresistance, and disease progression in high grade serous ovarian cancer (HGSOC). Cancers (Basel). 2022;14(5):1120. doi:10.3390/cancers14051120.
- Zhang S, Carlsen L, Hernandez Borrero L, Seyhan AA, Tian X, El-Deiry WS. Advanced strategies for therapeutic targeting of wild-type and mutant p53 in cancer. Biomolecules. 2022;12(4):548. doi:10.3390/biom12040548.
- Izutsu M, Domoto T, Kamoshida S, Ohsaki H, Matsuoka H, Umeki Y, Shiogama K, Hirayama M, Suda K, Uyama I, et al. Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma. World J Surg Onc. 2022;20(1):105. doi:10.1186/s12957-022-02571-9.
- Tang T, Zhang DL. Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique. Oncol Lett. 2017 May;13(5):2937–44. doi:10.3892/ol.2017.5856.
- Wang KM, Ma L, Jin YF, et al. The protein expression and mutation of p53 gene in infantile hemangioma. Chin J Derm Venereol. 2010; 24(7):629–31.
- Redline RW, Boyd TK, Roberts DJ. Placental and gestational pathology. Beijing: Beijing Science and Technology Publishing Co., Ltd; 2020. p. 70–3.
- Baergen RN. Manual of Benirschke and Kaufmann’s pathology of the human placenta. Tianjin: Tianjin Science & Technology Translation & Publishing Co., Ltd.; 2008. p. 228–30.
- Altshuler G. Chorangiosis. an important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med. 1984;108(1):71–4.
- Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler HP. Human p53 gene localized to short arm of chromosome 17. Nature. 1986;319(6056):783–4. doi:10.1038/319783a0.
- Kumar V, Abbas AK, Aster JC. Robbins and Cotran’s pathologic basis of disease. 9th ed. Philadelphia: Elsevier; 2015. p. 290–6.
- Zhang C, Liu J, Xu D, Zhang T, Hu W, Feng Z. Gain-of-function mutant p53 in cancer progression and therapy. J Mol Cell Biol. 2020;12(9):674–87. doi:10.1093/jmcb/mjaa040.
- Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, Li X, Babur O, Hsu T-K, Lichtarge O, et al. Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas. Cell Rep. 2019;28(5):1370–84.e5. doi:10.1016/j.celrep.2019.07.001.